None
Quote | Oncocyte Corporation (NYSE:OCX)
Last: | $4.805 |
---|---|
Change Percent: | 4.57% |
Open: | $4.58 |
Close: | $4.805 |
High: | $5 |
Low: | $4.55 |
Volume: | 2,265,701 |
Last Trade Date Time: | 03/19/2021 04:10:44 am |
News | Oncocyte Corporation (NYSE:OCX)
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the precision diagnostics company, Oncocyte’s (Nasdaq: OCX) appointment of leading finance executive, Andrea Jame...
2024-06-17 16:20:34 ET More on OncoCyte OncoCyte Corporation (OCX) Q1 2024 Earnings Call Transcript Oncocyte stock rallies 90% post-market on Bio-Rad partnership Seeking Alpha’s Quant Rating on OncoCyte Historical earnings data for OncoCyte R...
Message Board Posts | Oncocyte Corporation (NYSE:OCX)
Subject | By | Source | When |
---|---|---|---|
$OCX short squeeze | MikeKato2002 | investorshub | 05/09/2023 11:03:57 PM |
what do you make of this data? | jdheart101 | investorshub | 05/09/2023 5:12:32 AM |
$OCX Price now last up | jdheart101 | investorshub | 05/08/2023 8:51:18 PM |
best news of the day | georgie18 | investorshub | 05/06/2023 11:37:40 PM |
$OCX Long and strong lets hope im right | pymadams | investorshub | 05/05/2023 10:37:03 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, June 24, 2024 (GLOBE NEWSWIRE) -- PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting the precision diagnostics company, Oncocyte’s (Nasdaq: OCX) appointment of leading finance executive, Andrea Jame...
IRVINE, Calif., June 17, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (Nasdaq: OCX), a precision diagnostics company, today announced that it has appointed leading finance executive, Andrea James, to the position of Chief Financial Officer. “We are thrilled to welcome Andrea...
(NewsDirect) Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For organ transplant patients, the risk of graft rejection remains a persistent threa...